Status:
COMPLETED
CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse
Lead Sponsor:
British Columbia Cancer Agency
Conditions:
Prostate Cancer
Interstitial Radiation
Eligibility:
MALE
45-80 years
Phase:
NA
Brief Summary
High Dose Rate (HDR) temporary prostate brachytherapy offers a precise form of dose escalation for prostate cancer. Needles are placed, the position is confirmed and treatment is delivered. Previously...
Detailed Description
Twenty men with intermediate risk prostate cancer, suitable for the combination of external beam radiotherapy and High Dose Rate brachytherapy will be entered in this study. High Dose Rate brachythera...
Eligibility Criteria
Inclusion
- Patients must have histologically proven adenocarcinoma of the prostate.
- Patients must have intermediate risk prostate cancer. (Clinical stage ≤ T2c, Gleason score = 7 and initial prostate specific antigen (iPSA) ≤ 20, or Gleason score ≤ 6 and iPSA \> 10 and ≤ 20.
- Patients must be fit for general or spinal anaesthetic.
- Patients must have an estimated life expectancy of at least 10 years.
- Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2.
- Patients must have no contraindications to interstitial prostate brachytherapy.
- Patients on coumadin therapy must be able to stop therapy safely for at least 7 days.
Exclusion
- Men not able to fully understand the trial and the informed consent document
- Men suffering from claustrophobia and unable to have a Computed Tomography scan
- Men not wishing to have a cone-beam Computed Tomography scan following the insertion of the High Dose Rate brachytherapy needles to verify the accuracy of the treatment plan
- Men who cannot safely discontinue blood thinners for a few days.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01248741
Start Date
December 1 2010
End Date
May 1 2012
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BCCA Center for the Southern Interior
Kelowna, British Columbia, Canada, V1Y 5L3